On April 15, Ge Longhui (300685.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 1,044 million yuan, up 23.91% year on year; net profit attributable to shareholders of listed companies was 261 million yuan, down 0.86% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 239 million yuan, up 52.21% year on year; basic income per share was 0.66 yuan; it plans to distribute a cash dividend of 1.5 yuan (tax included) to all shareholders for every 10 shares.
艾德生物(300685.SZ)：2023年度净利润降0.86%至2.61亿元 拟10派1.5元
Ed Biotech (300685.SZ): Net profit for 2023 decreased by 0.86% to 261 million yuan, plans to pay 10 to 1.5 yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.